gabapentin has been researched along with Panic Disorder in 6 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Panic Disorder: A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized, double-blind, placebo-controlled, parallel-group study was conducted to evaluate the efficacy and safety of gabapentin in relieving the symptoms of panic disorder." | 9.09 | Placebo-controlled study of gabapentin treatment of panic disorder. ( Chouinard, G; Crockatt, J; Dager, SR; Greiner, M; Lydiard, RB; Pande, AC; Pollack, MH; Shiovitz, T; Taylor, CB, 2000) |
| "A randomized, double-blind, placebo-controlled, parallel-group study was conducted to evaluate the efficacy and safety of gabapentin in relieving the symptoms of panic disorder." | 5.09 | Placebo-controlled study of gabapentin treatment of panic disorder. ( Chouinard, G; Crockatt, J; Dager, SR; Greiner, M; Lydiard, RB; Pande, AC; Pollack, MH; Shiovitz, T; Taylor, CB, 2000) |
| "Six subjects with panic disorder underwent sodium lactate infusions in conjunction with magnetic resonance spectroscopic imaging (MRSI) at study entrance when actively symptomatic and after clinical improvement while under treatment with gabapentin." | 5.09 | Brain metabolic changes during lactate-induced panic: effects of gabapentin treatment. ( Dager, SR; Friedman, SD; Layton, ME, 2001) |
| "Pharmacologic treatments for panic disorder and social phobia have been available since the early 1960s." | 2.40 | Panic disorder and social phobia: current treatments and new strategies. ( Connor, KM; Davidson, JR; Sutherland, SM, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joos, AA | 1 |
| Zeeck, A | 1 |
| Himmerich, H | 1 |
| Nickel, T | 1 |
| Dalal, MA | 1 |
| Müller, MB | 1 |
| Pollack, MH | 2 |
| Matthews, J | 1 |
| Scott, EL | 1 |
| Pande, AC | 1 |
| Crockatt, J | 1 |
| Greiner, M | 1 |
| Chouinard, G | 1 |
| Lydiard, RB | 1 |
| Taylor, CB | 1 |
| Dager, SR | 2 |
| Shiovitz, T | 1 |
| Layton, ME | 1 |
| Friedman, SD | 1 |
| Davidson, JR | 1 |
| Connor, KM | 1 |
| Sutherland, SM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Gabapentin on Postoperative Opioid Analgesic Use and Pain in Adolescents Undergoing Tonsillectomy[NCT05024825] | Phase 4 | 17 participants (Actual) | Interventional | 2017-08-04 | Terminated (stopped due to recruitment target not met.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for gabapentin and Panic Disorder
| Article | Year |
|---|---|
Panic disorder and social phobia: current treatments and new strategies.
Topics: Acetates; Amines; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Cost-Benefit Analysis; Cycl | 1998 |
2 trials available for gabapentin and Panic Disorder
| Article | Year |
|---|---|
Placebo-controlled study of gabapentin treatment of panic disorder.
Topics: Acetates; Adolescent; Adult; Aged; Agoraphobia; Amines; Anti-Anxiety Agents; Cyclohexanecarboxylic A | 2000 |
Brain metabolic changes during lactate-induced panic: effects of gabapentin treatment.
Topics: Acetates; Adult; Amines; Arousal; Aspartic Acid; Brain; Cyclohexanecarboxylic Acids; Double-Blind Me | 2001 |
3 other studies available for gabapentin and Panic Disorder
| Article | Year |
|---|---|
Gabapentin in somatoform and panic disorder.
Topics: Amines; Anti-Anxiety Agents; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Human | 2013 |
[Gabapentin treatment in a female patient with panic disorder and adverse effects under carbamazepine during benzodiazepine withdrawal].
Topics: Aged; Alprazolam; Amines; Antimanic Agents; Benzodiazepines; Carbamazepine; Chemical and Drug Induce | 2007 |
Gabapentin as a potential treatment for anxiety disorders.
Topics: Acetates; Adult; Alprazolam; Amines; Anticonvulsants; Anxiety Disorders; Cyclohexanecarboxylic Acids | 1998 |